News

Technology News

Benchmark Co-Founder Starts Research Seed Program

Monday, March 19, 2007 9:00:00 AM PDT | VentureDeal Staff
PALO ALTO, CA -- Benchmark Capital co-founder Andrew Rachleff is bringing a venture capital approach to funding cancer research.

Rachleff and his wife Debra have created an innovative program that provides seed funds to scientists looking to work on high-risk, out of the box ideas.

Teaming up with the Damon Runyon Cancer Research Foundation, the Rachleff's are providing $5 million in funding to look for "home runs" instead of the more typical "base hits" that traditional research funding tries to achieve.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1